Corey Fyfe

1.1k total citations
16 papers, 840 citations indexed

About

Corey Fyfe is a scholar working on Molecular Medicine, Molecular Biology and Pollution. According to data from OpenAlex, Corey Fyfe has authored 16 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Medicine, 9 papers in Molecular Biology and 6 papers in Pollution. Recurrent topics in Corey Fyfe's work include Antibiotic Resistance in Bacteria (10 papers), Pharmaceutical and Antibiotic Environmental Impacts (6 papers) and Cancer therapeutics and mechanisms (5 papers). Corey Fyfe is often cited by papers focused on Antibiotic Resistance in Bacteria (10 papers), Pharmaceutical and Antibiotic Environmental Impacts (6 papers) and Cancer therapeutics and mechanisms (5 papers). Corey Fyfe collaborates with scholars based in United States, Italy and Canada. Corey Fyfe's co-authors include Joyce A. Sutcliffe, William J. O’Brien, Trudy H. Grossman, Xiao-Yi Xiao, Roger B. Clark, Diana K. Hunt, Agata L. Starosta, David M. Rothstein, Daniel N. Wilson and Louis Plamondon and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Cold Spring Harbor Perspectives in Medicine.

In The Last Decade

Corey Fyfe

16 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Corey Fyfe United States 12 510 304 235 162 150 16 840
Eliana S. Armstrong United States 12 509 1.0× 292 1.0× 238 1.0× 160 1.0× 98 0.7× 17 722
Michael A. Zhanel Canada 9 610 1.2× 389 1.3× 146 0.6× 275 1.7× 108 0.7× 10 877
Courtney K. Lawrence Canada 7 573 1.1× 367 1.2× 152 0.6× 204 1.3× 96 0.6× 11 803
Yuiko Takebayashi United Kingdom 8 539 1.1× 202 0.7× 235 1.0× 110 0.7× 78 0.5× 14 761
Haris Jahić United States 10 810 1.6× 503 1.7× 295 1.3× 262 1.6× 109 0.7× 13 994
Ruslan Tsivkovski United States 15 890 1.7× 522 1.7× 205 0.9× 250 1.5× 141 0.9× 16 1.0k
Jason Thresher United States 12 656 1.3× 406 1.3× 258 1.1× 275 1.7× 99 0.7× 19 892
Ronald Domalaon Canada 18 706 1.4× 329 1.1× 489 2.1× 157 1.0× 77 0.5× 23 1.1k
Kirk Nelson United States 16 905 1.8× 555 1.8× 320 1.4× 266 1.6× 141 0.9× 23 1.2k
Axel Dalhoff Germany 13 348 0.7× 250 0.8× 201 0.9× 248 1.5× 116 0.8× 24 780

Countries citing papers authored by Corey Fyfe

Since Specialization
Citations

This map shows the geographic impact of Corey Fyfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corey Fyfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corey Fyfe more than expected).

Fields of papers citing papers by Corey Fyfe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corey Fyfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corey Fyfe. The network helps show where Corey Fyfe may publish in the future.

Co-authorship network of co-authors of Corey Fyfe

This figure shows the co-authorship network connecting the top 25 collaborators of Corey Fyfe. A scholar is included among the top collaborators of Corey Fyfe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corey Fyfe. Corey Fyfe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Morrissey, Ian, Melanie Olesky, Stephen Hawser, et al.. (2019). In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017. Antimicrobial Agents and Chemotherapy. 64(3). 72 indexed citations
2.
Morrissey, Ian, Stephen Hawser, Sibylle Lob, et al.. (2019). In Vitro Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017. Antimicrobial Agents and Chemotherapy. 64(3). 15 indexed citations
3.
4.
Sun, Cuixiang, Diana K. Hunt, Corey Fyfe, et al.. (2017). Heterocyclyl tetracyclines. 2. 7-Methoxy-8-pyrrolidinyltetracyclines: discovery of TP-2758, a potent, orally efficacious antimicrobial against Gram-negative pathogens. The Journal of Antibiotics. 71(2). 287–297. 5 indexed citations
5.
Grossman, Trudy H., Corey Fyfe, William J. O’Brien, et al.. (2017). Fluorocycline TP-271 Is Potent against Complicated Community-Acquired Bacterial Pneumonia Pathogens. mSphere. 2(1). 26 indexed citations
6.
Sun, Cuixiang, Diana K. Hunt, Corey Fyfe, et al.. (2017). Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa. Journal of Medicinal Chemistry. 60(6). 2498–2512. 11 indexed citations
7.
Fyfe, Corey, et al.. (2016). Resistance to Macrolide Antibiotics in Public Health Pathogens. Cold Spring Harbor Perspectives in Medicine. 6(10). a025395–a025395. 166 indexed citations
8.
9.
Sun, Cuixiang, Diana K. Hunt, Chi-Li Chen, et al.. (2015). Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents. Journal of Medicinal Chemistry. 58(11). 4703–4712. 14 indexed citations
10.
Clark, Roger B., Cuixiang Sun, Chi-Li Chen, et al.. (2013). Synthesis and Biological Evaluation of 8-Aminomethyltetracycline Derivatives as Novel Antibacterial Agents. Journal of Medicinal Chemistry. 56(20). 8112–8138. 12 indexed citations
11.
Sutcliffe, Joyce A., et al.. (2013). Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens. Antimicrobial Agents and Chemotherapy. 57(11). 5548–5558. 183 indexed citations
12.
Fyfe, Corey, Joyce A. Sutcliffe, & Trudy H. Grossman. (2012). Development and characterization of a Pseudomonas aeruginosa in vitro coupled transcription–translation assay system for evaluation of translation inhibitors. Journal of Microbiological Methods. 90(3). 256–261. 5 indexed citations
13.
Grossman, Trudy H., Agata L. Starosta, Corey Fyfe, et al.. (2012). Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic. Antimicrobial Agents and Chemotherapy. 56(5). 2559–2564. 129 indexed citations
14.
Xiao, Xiao-Yi, Diana K. Hunt, Jingye Zhou, et al.. (2011). Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A Potent, Broad Spectrum Antibacterial Agent. Journal of Medicinal Chemistry. 55(2). 597–605. 102 indexed citations
15.
Clark, Roger B., Diana K. Hunt, Chi-Li Chen, et al.. (2011). Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy. Journal of Medicinal Chemistry. 55(2). 606–622. 59 indexed citations
16.
Clark, Roger B., Corey Fyfe, William J. O’Brien, et al.. (2011). 8-Azatetracyclines: Synthesis and Evaluation of a Novel Class of Tetracycline Antibacterial Agents. Journal of Medicinal Chemistry. 54(5). 1511–1528. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eliana S. Armstrong Breakdown of academic impact, for papers by Michael A. Zhanel Breakdown of academic impact, for papers by Courtney K. Lawrence Breakdown of academic impact, for papers by Yuiko Takebayashi Breakdown of academic impact, for papers by Haris Jahić Breakdown of academic impact, for papers by Ruslan Tsivkovski Breakdown of academic impact, for papers by Jason Thresher Breakdown of academic impact, for papers by Ronald Domalaon Breakdown of academic impact, for papers by Kirk Nelson Breakdown of academic impact, for papers by Axel Dalhoff
Rankless by CCL
2026